ATP suppression of interleukin-12 and tumour necrosis factor-α release from macrophages

British Journal of Pharmacology

Volumn 129, Issue 5, 2000, Pages 909-914

  Haskó, György ^a   Kuhel, David G ^a   Salzman, Andrew L ^a   Szabó, Csaba ^a  

^a INOTEK CORPORATION   (United States)

Author keywords

Adenosine; Anti CD3 antibody; ATP; Interleukin 10; Interleukin 12; Lipopolysaccharide; Nucleotide; Purinergic; T helper 1; T helper 2

Indexed keywords

ADENOSINE DEAMINASE; ADENOSINE TRIPHOSPHATE; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0034097151     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703134     Document Type: Article

References (33)

1. Bodin, P. & Burnstock, G. (1998). Increased release of ATP from endothelial cells during acute inflammation, Inflamm. Res., 47, 351-354.
2. - TCR-gamma delta-expressing peripheral T cells. J. Immunol., 142, 3754-3762.
3. D'Andrea, A., Aste-Amezaga, M., Valiante, N.M., MA, X., Kubin, M. & Trinchieri, G. (1993). Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med., 178, 1041-1048.
4. Denlinger, L.C., Fisette, P.L., Garis, K A., Kwon, G., Vazquez-Torres, A., Simon, A.D., Nguyen, B., Proctor, R.A., Bertics, P.J. & Corbett, J.A. (1996). Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J. Biol. Chem., 271, 337-342.
5. Di Virgilio, F. (1995). The P2Z purinoreceptor: an intriguing role in immunity, inflammation and cell death. Immunol. Today, 16, 524-528.
6. 2-purinergic receptors for extracellular ATP and other nucleotides. Am. J. Physiol., 265, C577-C606.
7. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S. & Di Virgilio, F. (1997a). Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med., 185, 579-582.
8. KB through the P2Z purinoreceptor by selectively targeting NF-kappaB p65 (Rel A). J. Cell. Biol., 139, 1635-1643.
9. Gately, M.K., Renzetti, L.M., Magram, J., Stern, A.S., Adorini, L., Gubler, U. & Presky, D.H. (1998). The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol., 16, 495-521.
10. Germann, T., Szeliga, J., Hess, H., Strökel, J., Podlaski, F.J., Gately, M.K., Schmitt, E. & Rüde, E. (1995). Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. U.S.A. 92, 4823-4827.
11. Greenberg, S.S., Ouyang, J., Zhao, X., Xie, J., Wang, J.F. & Giles, T.D. (1997a). Interaction of ethanol with inducible nitric oxide synthase messenger RNA and protein: direct effects on autacoids and endotoxin in vivo. J. Pharmacol. Exp. Ther., 282, 1044-1054.
12. 2y receptors upregulate and enhance inducible No synthase mRNA and protein in vitro. Am. J. Physiol., 273, L967-L979.
13. Haskó, G., Kuhel, D.G., Németh, Z.H., Mabley, J.G., Stachlewitz, R.F., Viràg, L., Lohinai, Z., Southan, G.J., Salzman, A.L. & Szabó, C. (2000). Inosine inhibits inflammatory cytokine production by a post-transcriptional mechanism and protects against endotoxin-induced shock. J. Immunol., in press.
14. Haskó, G. & Szabó, C. (1998). Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomie nervous system. Biochem. Pharmacol., 56, 1079-1087.
15. Haskó, G. & Szabó, C. (1999). IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br. J. Pharmacol., 127, 1295-1304.
16. Haskó G., Szabó, C., Németh, Z.H., Kvetan, V., Pastores, S.M. & Vizi, E.S. (1996). Adenosine receptor agonists differentially regulate IL-10, TNF-x, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol., 157, 4634-4640.
17. Haskó, G., Virág, L., Egnacyzyk, G., Salzman, A.L. & Szabó, C. (1998). The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur. J. Immunol., 28, 1417-1425.
18. Hogquist, K.A., Nett, M.A., Unanue, E.R. & Chaplin, D.D. (1991). Interleukin-1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. U.S.A., 88, 8485-8489.
19. Kitching, A.R., Tipping, P.G. & Holdsworth, S.R. (1999). IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur. J. Immunol., 29, 1-10.
20. Leonard, J.P., Waldburger, K.E. & Goldman, S.J. (1995). Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 181, 381-386.
21. Mohaupt, M.G., Fisher, T., Schwobel, J., Sterzel. R.B. & Schulze-Lohoff, E. (1998). Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells. Am. J. Physiol., 275, F103-F110.
22. Neurath, M.F., Fuss, I., Kelsall, B.L., Stuber, E. & Strober, W. (1995). Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med., 182, 1281-1290.
23. Ozmen, L., Pericin, M., Hakimi, J., Chizzonite, R.A., Wysocka, M., Trinchiert, G., Gately, M. & Garotta, G. (1994). Interleukin 12, interferon gamma, and tumor necrosis factor α are the key cytokines of the generalized Shwartzman reaction. J. Exp. Med., 180, 907-915.
24. 2-agonists prevent TH1 development by selective inhibition of interleukin 12. J. Clin. Invest., 100, 1513-1519.
25. Ralevic, A. & Burnstock, G. (1998). Receptors for purines and pyrimidines. Pharmacol. Rev., 50, 413-492.
26. Smith, P.T., Armstrong, J., Koshiba, M., Huang, S., Apasov, S. & Sitkovsky, M. (1998). Studies of expression and possible-functional role of purinergic receptors in cell-mediated immunity: experimental approaches, controls, and caveats. Drug. Dev. Res., 45, 229-244.
27. Snijders, A., Hilkens, C.M.U., Van Der Pouw Kraan, T.C.T.M., Engel, M., Aarden, L.A. & Kapsenberg, M.L. (1996). Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol., 156, 1207-1212.
28. Sperlágh, B., Haskó, G., Németh, Z.H. & Vizi, E.S. (1998). ATP released by lipopolysaccharide increases nitric oxide production in RAW 264.7 macrophages via P2Z/P2X7 receptors. Neurochem. Int., 33, 209-215.
29. Tonetti, M., Sturla, L., Bistolfi, T., Benatti, T. & De Flora, A. (1994). Extracellular ATP potentiates nitric oxide synthasc expression induced by lipopolysaccharide in RAW 264.7 murine macrophages. Bioehem. Biophys. Res. Commun., 203, 430-435.
30. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K. & Adorini, L. (1995). Interleukin 12 administration induces T helper type I cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817-821.
31. Trinchieri, G. (1995). Interleukin-12: a proinflammatory cytokine with immunoregulalory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol., 13, 251-276.
32. White, T.D. & MacDonald, W.F. (1990). Neural release of ATP and adenosine. Ann. N.Y. Acad. Sci., 603, 287-298.
33. Wysocka, M., Kubin, M., Vieira, L.Q., Ozmen, L., Garrotta, G., Scott, P. & Trinchieri, G. (1995). Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol., 25, 672-676.